These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9204395)

  • 1. A novel synthetic inhibitor of endopeptidase-24.15.
    Ukai Y; Li Q; Ito S; Mita S
    J Enzyme Inhib; 1996 Aug; 11(1):39-49. PubMed ID: 9204395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
    Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
    Chappell MC; Welches WR; Brosnihan KB; Ferrario CM
    Peptides; 1992; 13(5):943-6. PubMed ID: 1336190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.
    Shrimpton CN; Abbenante G; Lew RA; Smith I
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):351-6. PubMed ID: 10620512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
    Cardozo C; Orlowski M
    Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids.
    Steer D; Lew R; Perlmutter P; Smith AI; Aguilar MI
    Biochemistry; 2002 Sep; 41(35):10819-26. PubMed ID: 12196021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Ksander GM; Savage P; Trapani AJ; Balwierczak JL; Jeng AY
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S71-3. PubMed ID: 9595404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
    Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
    Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of inhibitors incorporating beta -amino acids of metalloendopeptidase EC 3.4.24.15.
    Steer DL; Lew RA; Perlmutter P; Smith AI; Aguilar MI
    J Pept Sci; 2000 Sep; 6(9):470-7. PubMed ID: 11016884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.
    Williams CH; Yamamoto T; Walsh DM; Allsop D
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):681-4. PubMed ID: 8379924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.
    Inguimbert N; Poras H; Dhotel H; Beslot F; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
    J Pept Res; 2004 Feb; 63(2):99-107. PubMed ID: 15009531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
    Molineaux CJ; Ayala JM
    J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.
    Inguimbert N; Poras H; Teffo F; Beslot F; Selkti M; Tomas A; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2001-5. PubMed ID: 12113828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Trapani AJ; Beil ME; Bruseo CW; Savage P; Firooznia F; Jeng AY
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE).
    Melzig MF; Pieper S; Siems WE; Heder G; Bóttger A; Liberra K; Lindequist U
    Pharmazie; 1996 Jul; 51(7):501-3. PubMed ID: 8774843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.